Date of Award
12-2026
Document Type
Thesis
Degree Name
Master of Science in Biology
Department
Biology
First Reader/Committee Chair
Bournias-Vardiabasis, Nicole
Abstract
Retinoblastoma is a pediatric retinal cancer primarily driven by the biallelic inactivation of the RB1 tumor suppressor gene. Studies have shown that maturing cone precursors are the cell types vulnerable to developing retinoblastoma after RB1 loss. Following the loss of RB1 there is reactivation of the cell cycle in these cells, leading to proliferation, causing the formation of retinoblastoma-like lesions. A gene that is potentially vital for proper cone development is MYCN, a proto-oncogene known in many cancers to drive proliferation. In RB1 wild-type cone precursors, MCYN RNA and MYCN protein are intrinsically expressed but cone cells maintain a normal state of development. After the loss of RB1, MYCN is thought to promote the re-entry into the cell cycle, resulting in proliferation. Since maturing cone precursors do not proliferate during normal development, these observations suggest that MYCN may help maintain cone precursors in a transient immature state preceding MYCN down-regulation and terminal differentiation. However, the exact role of intrinsic MYCN expression in early human cone precursors remains unclear.
The goal described in this study was to develop a system that enables temporal and cone-specific control of gene expression in human induced pluripotent stem cell (iPSC)-derived human retinal organoids (hROs) . We developed a cone-specific “Cre-loxP” recombination system that introduced a Cre recombinase protein recognizing specific DNA called loxP sites and mediates recombination removing DNA in between loxP flanked sites, which allows targeted manipulation of gene expression. We introduced an ERT2-Cre-ERT2-T2A cassette sequence consisting of two estrogen ligand binding domains flanking the Cre coding sequence and followed by a ‘T2A’ peptide-bond-skipping peptide under the cone-specific GNAT2 promoter, in two previously generated GNAT2EGFP/- iPSC cell lines. Generated lines were validated through PCR and Sanger sequencing, establishing two cone-specific tamoxifen-inducible Cre iPSC lines. In order to validate Cre recombinase activity, two Cre-dependent reporter systems were generated targeting the AAVS1 safe harbor locus. The first construct contained a loxP-stop-stop-stop-loxP (LSSSL) cassette upstream a mMaroon1 sequence preventing the expression of the fluorescent reporter, a second construct included the same LSSSL and mMaroon constructs only with addition of a MYCN overexpressing cassette upstream of T2A-mMaroon1. Following transient electroporation of a ERT2-Cre-ERT2 expression plasmid with the addition of tamoxifen treatment mMaroon expression should be expressed following recombination and analyzed by flow cytometry to quantify Cre-mediated recombination efficiency. ALmM cells showed a 37.3% positive fluorescence, and MYCN_ALmM a 63.9% positive fluorescence of mMaroon1 expressing cells.
Together these studies establish a tamoxifen-inducible and cone-specific Cre-loxP system in human iPSCs. This system will be used in future human retinal organoid studies to selectively knock out or overexpress MYCN during defined stages of cone development and investigate its role in retinoblastoma, contributing new information to understanding the role MYCN plays in cone precursor development and the molecular mechanism underlying retinoblastoma development.
Recommended Citation
Ramirez, Cindy J., "DEVELOPMENT AND VALIDATION OF A CONE-SPECIFIC INDUCIBLE CRE-LOXP SYSTEM FOR STUDYING MYCN IN HUMAN RETINAL ORGANOIDS" (2026). Electronic Theses, Projects, and Dissertations. 2556.
https://scholarworks.lib.csusb.edu/etd/2556
Included in
Biology Commons, Biotechnology Commons, Genetics and Genomics Commons, Laboratory and Basic Science Research Commons, Research Methods in Life Sciences Commons